Table 4. C-index of RCB class and Miller‐Payne system for DFS and DSS.
Subtype | Staging system | C-index for DFS | P | C-index for DSS | P |
---|---|---|---|---|---|
Whole cohort | RCB | 0.73 | <0.0001 | 0.74 | 0.0003 |
Miller-Payne | 0.64 | 0.64 | |||
Luminal | RCB | 0.64 | 0.001 | 0.72 | 0.021 |
Miller-Payne | 0.53 | 0.57 | |||
HER2+ | RCB | 0.66 | 0.108 | 0.56 | 0.405 |
Miller-Payne | 0.62 | 0.52 | |||
TNBC | RCB | 0.83 | 0.002 | 0.84 | 0.0006 |
Miller-Payne | 0.72 | 0.72 |
C-index, concordance-index; RCB, residual cancer burden; DFS, disease-free survival; DSS, disease-specific survival; HER2, human epidermal growth factor receptor 2; TNBC, triple negative breast cancer.